Literature DB >> 30375548

Evaluation of Tryptophan/Kynurenine Pathway Relevance With Immune System Biomarkers of Low Energy Trauma Hip Fractures in Osteoporotic Patients.

Ercan Dinçel1, Yeşim Özkan2, Murat Şüküroğlu3, Hakan Özsoy1, Aylin Sepici Dinçel4.   

Abstract

OBJECTIVES: This study aims to evaluate tryptophan degradation and clarify whether altered levels of kynurenine and tryptophan (Kyn/Trp) ratio could be correlated to osteoporotic hip fractures via immune system. PATIENTS AND METHODS: The study included 60 patients with osteoporotic hip fracture (20 males, 40 females, mean age 76.6±6.9 years; range 59 to 95 years). Patients were divided into two as patients with collum femoris fractures (group 1; n=23) and intertrochanteric fractures (group 2; n=37). Fifteen healthy subjects without any fracture were selected as control group (group 3; 3 males, 12 females; mean age 69.7±8.4; range 60 to 86 years). All fractures were simple falls due to low energy trauma. Bone mineral density measurements were performed with Lunar dual energy X-ray absorptiometry. Kyn/Trp levels were measured by high performance liquid chromatography. Interleukin (IL)-6 and IL-1 beta levels were measured with solid-phase sandwich enzyme-linked immunosorbent assay.
RESULTS: All bone mineral density values were in agreement for osteoporosis and there was no significant difference between the two groups. Higher Kyn/Trp ratios were observed in groups 1 and 2 compared to group 3. This difference was more significant in group 1 (p=0.0001) than that in group 2 (p=0.048). Also, group 1 had significantly higher Kyn/Trp ratio than group 2 (p=0.011). There were significantly higher IL-6 and lower IL-1 beta levels both in groups 1 and 2 compared to group 3 (p=0.0001). There was no significant difference between group 1 and group 2 in terms of IL-6 and IL-1 beta levels. There was positive correlation with Kyn/Trp ratio (r=0.581, p=0.004) in group 2. Also, significant correlation was detected between IL-6 and IL-1 beta levels in the same group (r=0.665, p=0.036).
CONCLUSION: Both increased degradation of tryptophan and ratio of Kyn/Trp indicate the relationship of immune activation with bone healing.

Entities:  

Keywords:  3-dioxygenase; kynurenine; osteoporosis; tryptophan; Bone regeneration; indoleamine 2

Year:  2017        PMID: 30375548      PMCID: PMC6190949          DOI: 10.5606/ArchRheumatol.2017.6216

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  29 in total

Review 1.  Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS.

Authors:  R R Brown; Y Ozaki; S P Datta; E C Borden; P M Sondel; D G Malone
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

2.  Intertrochanteric versus femoral neck hip fractures: differential characteristics, treatment, and sequelae.

Authors:  K M Fox; J Magaziner; J R Hebel; J E Kenzora; T M Kashner
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1999-12       Impact factor: 6.053

3.  Inflammatory markers and the risk of hip fracture: the Women's Health Initiative.

Authors:  Kamil E Barbour; Robert Boudreau; Michelle E Danielson; Ada O Youk; Jean Wactawski-Wende; Nancy C Greep; Andrea Z LaCroix; Rebecca D Jackson; Robert B Wallace; Douglas C Bauer; Matthew A Allison; Jane A Cauley
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

4.  Molecular mechanism of nitric oxide-induced osteoblast apoptosis.

Authors:  Ruei-Ming Chen; Ta-Liang Chen; Wen-Ta Chiu; Chia-Chen Chang
Journal:  J Orthop Res       Date:  2005-03       Impact factor: 3.494

5.  Leptin is a negative independent predictor of areal BMD and cortical bone size in young adult Swedish men.

Authors:  Mattias Lorentzon; Kerstin Landin; Dan Mellström; Claes Ohlsson
Journal:  J Bone Miner Res       Date:  2006-12       Impact factor: 6.741

6.  High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study.

Authors:  Georg Schett; Stefan Kiechl; Siegfried Weger; Angelo Pederiva; Agnes Mayr; Manuele Petrangeli; Friedrich Oberhollenzer; Rolando Lorenzini; Kurt Redlich; Roland Axmann; Jochen Zwerina; Johann Willeit
Journal:  Arch Intern Med       Date:  2006 Dec 11-25

7.  C-reactive protein, bone strength, and nine-year fracture risk: data from the Study of Women's Health Across the Nation (SWAN).

Authors:  Shinya Ishii; Jane A Cauley; Gail A Greendale; Carolyn J Crandall; Michelle E Danielson; Yasuyoshi Ouchi; Arun S Karlamangla
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

Review 8.  Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease.

Authors:  Amos A Fatokun; Nicholas H Hunt; Helen J Ball
Journal:  Amino Acids       Date:  2013-10-09       Impact factor: 3.520

Review 9.  Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

Authors:  David H Munn; Andrew L Mellor
Journal:  Trends Immunol       Date:  2012-10-25       Impact factor: 16.687

10.  Interferon gamma (IFN-γ)-mediated inflammation and the kynurenine pathway in relation to risk of hip fractures: the Hordaland Health Study.

Authors:  E M Apalset; C G Gjesdal; P M Ueland; J Øyen; K Meyer; Ø Midttun; G E Eide; G S Tell
Journal:  Osteoporos Int       Date:  2014-05-10       Impact factor: 4.507

View more
  3 in total

1.  Chronic dietary supplementation with kynurenic acid, a neuroactive metabolite of tryptophan, decreased body weight without negative influence on densitometry and mandibular bone biomechanical endurance in young rats.

Authors:  Ewa Tomaszewska; Siemowit Muszyński; Damian Kuc; Piotr Dobrowolski; Krzysztof Lamorski; Katarzyna Smolińska; Janine Donaldson; Izabela Świetlicka; Maria Mielnik-Błaszczak; Piotr Paluszkiewicz; Jolanta Parada-Turska
Journal:  PLoS One       Date:  2019-12-06       Impact factor: 3.240

2.  Age-related increase of kynurenine enhances miR29b-1-5p to decrease both CXCL12 signaling and the epigenetic enzyme Hdac3 in bone marrow stromal cells.

Authors:  Ahmed M Elmansi; Khaled A Hussein; Sergio Mas Herrero; Sudharsan Periyasamy-Thandavan; Alexandra Aguilar-Pérez; Galina Kondrikova; Dmitry Kondrikov; Nada H Eisa; Jessica L Pierce; Helen Kaiser; Ke-Hong Ding; Aisha L Walker; Xue Jiang; Wendy B Bollag; Mohammed Elsalanty; Qing Zhong; Xing-Ming Shi; Yun Su; Maribeth Johnson; Monte Hunter; Charles Reitman; Brian F Volkman; Mark W Hamrick; Carlos M Isales; Sadanand Fulzele; Meghan E McGee-Lawrence; William D Hill
Journal:  Bone Rep       Date:  2020-04-23

Review 3.  Metabolomics in Bone Research.

Authors:  Jingzhi Fan; Vahid Jahed; Kristaps Klavins
Journal:  Metabolites       Date:  2021-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.